文献速递前列腺癌

主动监测作为新诊断前列腺癌初始管理:PURC数据

Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC.
PubMed 文献 · J Urol · 2019-01-01

该研究分析了PURC协作组中新诊断前列腺癌男性接受主动监测的比例及差异。在1,880名符合条件男性中,NCCN极低危或低危者57.4%以主动监测为初始管理策略。年龄增长与主动监测显著相关(p<0.001),不良临床病理变量与主动监测使用减少相关,不同执业机构和医生间存在显著差异。

要点

  • NCCN极低危或低危前列腺癌男性中57.4%接受主动监测作为初始管理。
  • 年龄增长与主动监测使用显著相关(p<0.001),不良临床病理因素与使用减少相关。
  • 不同执业机构和医生间主动监测使用率存在显著差异。

核心结论

  • PURC协作组中超过50%的低危前列腺癌男性接受了主动监测,但学术和社区机构的不同执业者间主动监测率存在显著差异。
  • 高龄和有利的临床病理因素与主动监测强烈相关。

研究设计与样本

  • 分析PURC(宾夕法尼亚泌尿科区域协作组)数据,该协作组由宾夕法尼亚州东南部和新泽西州的泌尿科执业机构合作组成。
  • 共1,880名男性符合纳入标准,均为新诊断的NCCN极低危、低危或中危前列腺癌患者。
  • 比较参与执业机构和医生间的主动监测率,采用单变量和多变量分析识别与主动监测使用相关的因素。

主要发现

  • NCCN极低危或低危前列腺癌男性中57.4%以主动监测作为初始管理策略。
  • 年龄增长与主动监测显著相关(p<0.001)。
  • 不良临床病理变量与主动监测使用减少相关。
  • 不同执业机构和医生间主动监测使用率存在显著差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We describe contemporary active surveillance utilization and variation in a regional prostate cancer collaborative. We identified demographic and disease specific factors associated with active surveillance in men with newly diagnosed prostate cancer. MATERIALS AND METHODS: We analyzed data from the PURC (Pennsylvania Urologic Regional Collaborative), a cooperative effort of urology practices in southeastern Pennsylvania and New Jersey. We determined the rates of active surveillance among men with newly diagnosed NCCN® (National Comprehensive Cancer Network®) very low, low or intermediate prostate cancer and compared the rates among participating practices and providers. Univariate and multivariable analyses were used to identify factors associated with active surveillance utilization. RESULTS: A total of 1,880 men met inclusion criteria. Of the men with NCCN very low or low risk prostate cancer 57.4% underwent active surveillance as the initial management strategy. Increasing age was significantly associated with active surveillance (p <0.001) while adverse clinicopathological variables were associated with decreased active surveillance use. Substantial variation in active surveillance utilization was observed among practices and providers. CONCLUSIONS: More than 50% of men with low risk disease in the PURC collaborative were treated with active surveillance. However, substantial variation in active surveillance rates were observed among practices and providers in academic and community settings. Advanced age and favorable clinicopathological factors were strongly associated with active surveillance. Analysis of regional collaboratives such as the PURC may allow for the development of strategies to better standardize treatment in men with prostate cancer and offer active surveillance in a more uniform and systematic fashion.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Botejue M, Abbott D, Danella J, et al. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC. J Urol. 2019. PMID: 30720692. doi:10.1016/j.juro.2018.10.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。